Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 17, 2026 10:15 ET | Source: Research and Markets

Mancozeb Market Report 2026 with Analyst Recommendations - Ongoing Developments in Crop Protection Practice / Optimizing Supply Chains and Building Strong Local Distribution Networks

Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "Mancozeb Market (2026 Edition)" report has been added to ResearchAndMarkets.com's offering.The report analyses the Mancozeb Market by Region...
February 17, 2026 10:15 ET | Source: James Altucher, Tech Investor

As Starlink Expands, a Quiet Infrastructure Is Forming Around It

Washington, D.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- A newly released video presentation from technology analyst James Altucher is turning attention toward the growing ecosystem forming alongside...
February 17, 2026 10:13 ET | Source: Research and Markets

Immunotherapy Drugs Market Research and Forecast Report, 2020-2025/2025-2026 with Analyst Recommendations - Adoption of AI in Drug Discovery / Combination Therapies

Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market (2026 Edition)" report has been added to ResearchAndMarkets.com's offering.The global immunotherapy drugs market is...
February 17, 2026 10:12 ET | Source: Fast Ejendom Danmark

Forventning til årets resultat

Selskabet meddelte den 27. november 2025 i børsmeddelelse nr. 16, at man fortsat forventer et resultat af primær drift før værdireguleringer i niveauet 71 mio. kr. Dette niveau fastholdes. Herudover...
February 17, 2026 10:11 ET | Source: 24/7 Market News

AI, Advanced Materials and Enterprise Security Drive Small-Cap Momentum

Execution is the theme this morning, as a cluster of emerging growth stocks move from pilot programs and strategic roadmaps into operational scale.
February 17, 2026 10:10 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.
February 17, 2026 10:09 ET | Source: Schall Law

ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Fraud Lawsuit with the Schall Law Firm

ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Fraud Lawsuit with the Schall Law Firm
February 17, 2026 10:06 ET | Source: ARC (Association Of Related Churches)

The Association of Related Churches Highlights Anticipated Women’s Lunch & Learn Ahead of ARC Conference 2026

BIRMINGHAM, Ala., Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Association of Related Churches (ARC) is excited to announce the return of the ARC Women Lunch & Learn as part of ARC Conference 2026,...
February 17, 2026 10:05 ET | Source: Vectorworks, Inc.

Vectorworks Acquires Morpholio, Adding Leading Mobile Design Apps to its Product Line

Columbia, MD, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Global design and BIM software provider Vectorworks, Inc., part of the Nemetschek Group, is thrilled to announce it has acquired Morpholio, developer...
February 17, 2026 10:05 ET | Source: AFCI

AFCI Announces 2026 Board Reflecting the Global Scope of Film and Television Production

AFCI announces its 2026 board, adding representatives from Japan and South Africa and reflecting the global scope of film and TV production.